PF-Atlas › Clinical Trials › NCT03087929
Follow-up Trial of Rituximab Interferon Transplant Trial: Study Drug-Rituximab and Alpha Interferon
Follow up · Not specified
Registry ID
NCT03087929
Phase
Not specified
Status
Completed
Drug / intervention
Follow up
Sponsor
Sunnybrook Health Sciences Centre
Start
2013-09-20
Enrollment
12
Locations
1
About this trial
A previous phase II trial entitled Treatment of Follicular non-Hodgkin's Lymphoma with High Dose Therapy and Stem Cell Support Followed by Consolidative Immunotherapy with Rituximab and Alpha Interferon was conducted at the Odette Cancer Centre between 2005 and 2012. The primary objectives of this previous trial was to assess progression free survival and overall survival. Of the 36 patients in this trial, approximately 18 remain in remission. In this new follow up trial, follow up data will prospectively be collected on patients who provide informed consent to do so.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT03087929 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.